These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12623509)

  • 1. Long-term effects of losartan on proteinuria and renal function in patients with renal amyloidosis.
    Dilek K; Usta M; Ersoy A; Ozdemir B; Yavuz M; Güllülü M; Yurtkuran M
    Scand J Urol Nephrol; 2002; 36(6):443-6. PubMed ID: 12623509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria.
    Ellis D; Vats A; Moritz ML; Reitz S; Grosso MJ; Janosky JE
    J Pediatr; 2003 Jul; 143(1):89-97. PubMed ID: 12915830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.
    Lin SL; Chen YM; Chiang WC; Wu KD; Tsai TJ
    Am J Kidney Dis; 2008 Sep; 52(3):464-74. PubMed ID: 18617301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline].
    Renke M; Rutkowski P; Tylicki L; Zietkiewicz M; Larczyński W; Rutkowski B
    Przegl Lek; 2008; 65(6):312-4. PubMed ID: 18853664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin II type-1 receptor blockers on stable allograft kidneys: prospective randomized study.
    Nouri-Majalan N; Ghafari A; Moghaddasi S
    Transplant Proc; 2009 Sep; 41(7):2832-4. PubMed ID: 19765449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of angiotensin II receptor antagonist (losartan) on renal function, serum potassium and blood pressure in patients with advanced renal failure: differences between patients with a serum creatinine (SCr) level higher than 3 mg/dl and those with a lower SCr level].
    Nakayama M; Tanno Y; Otsuka Y; Takahashi H; Ikeda M; Katoh N; Yokoyama K; Yamamoto H; Tokutome G; Hosoya T
    Nihon Jinzo Gakkai Shi; 2002 Oct; 44(7):530-6. PubMed ID: 12476589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct time courses of renal protective action of angiotensin receptor antagonists and ACE inhibitors in chronic renal disease.
    Matsuda H; Hayashi K; Saruta T
    J Hum Hypertens; 2003 Apr; 17(4):271-6. PubMed ID: 12692572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto K
    Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of long-term leptin infusion and preventive role of losartan treatment in rats.
    Gunduz Z; Dursun N; Akgun H; Ozturk F; Okur H; Koc N
    Regul Pept; 2005 Dec; 132(1-3):59-66. PubMed ID: 16229907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of indomethacin and selective cyclooxygenase-2 inhibitors on proteinuria and renal function in patients with AA type renal amyloidosis.
    Kahvecioglu S; Dilek K; Akdag I; Gullulu M; Demircan C; Ersoy A; Yurtkuran M
    Nephrology (Carlton); 2006 Jun; 11(3):232-7. PubMed ID: 16756637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of losartan on proteinuria and urinary angiotensinogen excretion in non-diabetic patients with chronic kidney disease.
    Lee YJ; Cho S; Kim SR; Jang HR; Lee JE; Huh W; Kim DJ; Oh HY; Kim YG
    Postgrad Med J; 2011 Oct; 87(1032):664-9. PubMed ID: 21715572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protective effect of angiotensin II receptor blockage on rats with experimental diabetes nephropathy in early stage].
    Yang L; Fan J; Mi X; Liu X; Xu G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):317-9. PubMed ID: 12947726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study.
    Zhu X; Chen J; Han F; Cheng M; Xu L; Zhang L; Ding X; Le Y
    Transplant Proc; 2009 Nov; 41(9):3736-42. PubMed ID: 19917377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
    Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.
    Tylicki L; Renke M; Rutkowski P; Rutkowski B; Lysiak-Szydłowska W
    Med Sci Monit; 2005 Apr; 11(4):PI31-7. PubMed ID: 15795705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin II receptor blocker on proteinuria in renal transplant recipients.
    Tanji N; Ohoka H; Shimamoto K; Ikeda T; Miyauchi Y; Yokoyama M
    In Vivo; 2004; 18(4):433-6. PubMed ID: 15369180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.